David P. Hochman

David P. Hochman

Chief Executive Officer & ChairmanatOrchestra BioMed Holdings· In proxies 2022–2025

Pay in FY2025+18% from the year before · Orchestra BioMed Holdings stock +3.8% the same year

David P. Hochman was paid $2.3M in FY2025 (Dec), up 18%. Orchestra BioMed Holdings stock rose 3.8% that year.

Pay$100 in the stock at the end of FY21 → $41
Pay is from the Summary Compensation Table of each Orchestra BioMed Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Orchestra BioMed HoldingsPublic company · 4 yr
    • Chief Executive Officer & Chairman2022 – Present · 4 yrStock in role -39%
  2. BackBeatPublic company · 18 yr
    • Director2008 – Present · 18 yrNo stock prices for these years
  3. Caliber, FreeHoldPublic company
    • Director? – PresentNo stock prices for these years
  4. Vivasure Medical LimitedPublic company · 7 yr
    • Director2019 – 2026 · 7 yrNo stock prices for these years
  5. Motus GIPublic company · 7 yr
    • Director2016 – 2023 · 7 yrNo stock prices for these years
  6. Corbus Pharmaceuticals Holdings, Inc.Public company · 7 yr
    • Director2013 – 2020 · 7 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?